MREO (Mereo BioPharma Group) Days Payable: 0.00 (As of Mar. 2026)


MREO Mereo BioPharma Group PLC MREO
19 GF Score
Price $0.33
! 1 Warning Sign
View Full Analysis

What is Mereo BioPharma Group Days Payable?

Mereo BioPharma Group MREO +3.62% 19 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates MREO with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 702 Biotechnology companies, Mereo BioPharma Group ranks better than 94.3% on this metric.

Mereo BioPharma Group's average Accounts Payable for the three months ended in Mar. 2026 was $2.28 Mil. Mereo BioPharma Group's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Mereo BioPharma Group's Days Payable or its related term are showing as below:

MREO' s Days Payable Range Over the Past 10 Years
Min: 18.67   Med: 57.82   Max: 5253.79
Current: 5253.79

During the past 11 years, Mereo BioPharma Group's highest Days Payable was 5253.79. The lowest was 18.67. And the median was 57.82.

MREO's Days Payable is ranked better than
94.3% of 702 companies
in the Biotechnology industry
Industry Median: 113.56 vs MREO: 5253.79

Mereo BioPharma Group's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Mereo BioPharma Group Days Payable Historical Data

* Premium members only.

The historical data trend for Mereo BioPharma Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mereo BioPharma Group Days Payable Chart

Mereo BioPharma Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.85 0.00 413.92 0.00 5,177.24

Mereo BioPharma Group Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,404.01 0.00 0.00 0.00

MREO vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Mereo BioPharma Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's Days Payable falls into.


MREO
19GF Score
Mereo BioPharma Group PLC MREO
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mereo BioPharma Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mereo BioPharma Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (2.44 + 1.333) / 2 ) / 0.133*365
=1.8865 / 0.133*365
=5,177.24

Mereo BioPharma Group's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (1.333 + 3.226) / 2 ) / 0*365 / 4
=2.2795 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Mereo BioPharma Group (MREO) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mereo BioPharma Group and its competitors. Over the past decade, Mereo BioPharma Group's Days Payable has ranged from 18.67 to 5,253.79. According to the industry distribution chart, Mereo BioPharma Group ranks #40 out of 702 companies in the Biotechnology industry, placing it in the top 5.7%.
Is Mereo BioPharma Group's Days Payable too high?
Mereo BioPharma Group's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 18.67 to a high of 5,253.79. Based on the distribution chart, Mereo BioPharma Group ranks #40 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Mereo BioPharma Group has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Mereo BioPharma Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Mereo BioPharma Group ranks #40 out of 702 companies for Days Payable. This places Mereo BioPharma Group in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Historically, Mereo BioPharma Group's own Days Payable has ranged from 18.67 to 5,253.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mereo BioPharma Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mereo BioPharma Group's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mereo BioPharma Group stock overvalued right now?
Mereo BioPharma Group (MREO) has a current Days Payable of 0.00. The current Days Payable is 0.00. Mereo BioPharma Group's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Mereo BioPharma Group (MREO), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mereo BioPharma Group Business Description

Other Exchanges 0A9G:UKMAH0:Germany
Address One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
19GF Score

Get the complete analysis for MREO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.33
Price